Követés
David Brown
David Brown
KBI Biopharma
E-mail megerősítve itt: kbibiopharma.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Nox proteins in signal transduction
DI Brown, KK Griendling
Free Radical Biology and Medicine 47 (9), 1239-1253, 2009
10372009
Regulation of signal transduction by reactive oxygen species in the cardiovascular system
DI Brown, KK Griendling
Circulation research 116 (3), 531-549, 2015
5502015
Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle–specific ubiquitin ligase MuRF1
MS Willis, TL Parry, DI Brown, RI Mota, W Huang, JY Beak, M Sola, ...
Circulation: Heart Failure 12 (3), e005234, 2019
1202019
NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor
A Martin-Garrido, DI Brown, AN Lyle, A Dikalova, B Seidel-Rogol, ...
Free Radical Biology and Medicine 50 (2), 354-362, 2011
1002011
Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts
DI Brown, B Lassègue, M Lee, R Zafari, JS Long, HI Saavedra, ...
PLoS One 9 (5), e96657, 2014
452014
Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4
Q Xu, AA Kulkarni, AM Sajith, D Hussein, D Brown, OF Güner, MD Reddy, ...
Bioorganic & medicinal chemistry 26 (5), 989-998, 2018
342018
Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis
A Ilaiwy, MT Quintana, JR Bain, MJ Muehlbauer, DI Brown, WE Stansfield, ...
The international journal of biochemistry & cell biology 79, 80-92, 2016
222016
Influence of Ischemia-Reperfusion Injury on Cardiac Metabolism
DI Brown, MS Willis, JM Berthiaume
The Scientist's Guide to Cardiac Metabolism, 155-167, 2016
152016
Ubiquitin ligases and posttranslational regulation of energy in the heart: the hand that feeds
DI Brown, TL Parry, MS Willis
Comprehensive Physiology 7 (3), 841-862, 2011
122011
Nebulized delivery of the MAPKAP kinase 2 peptide inhibitor MMI-0100 protects against ischemia-induced systolic dysfunction
DI Brown, BC Cooley, MT Quintana, C Lander, MS Willis
International journal of peptide research and therapeutics 22, 317-324, 2016
102016
Erratum to'Cessation of biomechanical stretch model of C2C12 cells modelsmyocyte atrophy and anaplerotic changes in metabolism usingnon-targeted metabolomics analysisAmro'[Int …
A Ilaiwy, MT Quintana, JR Bain, MJ Muehlbauer, DI Brown, WE Stansfield, ...
The international journal of biochemistry & cell biology 88, 238-240, 2017
12017
NADPH oxidase inhibitors and uses thereof
O Güner, B Lassegue, K Griendling, Q Xu, D Brown, JP Bowen, A Kulkarni, ...
US Patent 11,236,053, 2022
2022
Muscle Ring Finger‐1 Knockout (MuRF1−/−) Mice are Resistant to LPS‐induced Cardiac Dysfunction Due to Decreased NF‐κB Activity
TL Parry, DI Brown, JM Mwiza, MS Willis
The FASEB Journal 31, 59.6-59.6, 2017
2017
The absence of MuRF1 protects against Calpain1‐induced systolic dysfunction in vivo
D Brown, J Robbins*, M Willis
The FASEB Journal 29, 46.1, 2015
2015
Poldip2: an investigation of structure and signaling pathways to elucidate the function of a novel cell cycle regulator.
DI Brown
Emory University, 2013
2013
TGFβ Induction of Vascular Smooth Muscle Differentiation Markers is Mediated by Nox4 and p38 Mitogen-activated Protein Kinase
A Martin-Garrido, DI Brown, AN Lyle, A Dikalova, KK Griendling
Circulation 120 (suppl_18), S1098-S1098, 2009
2009
FRET Study of CAD-Rad9 Protein-Protein Interaction
DI Brown, EM Wauson, LM Graves
The FASEB Journal 20 (4), A46-A46, 2006
2006
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–17